The contribution of GABAergic dysfunction to neurodevelopmental disorders
Kartik Ramamoorthi1, Yingxi Lin
1McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
GABA (γ-aminobutyric acid) is key for brain E/I balance. Disruptions in GABAergic development cause neurodevelopmental disorders, but targeting this system may offer effective treatments.
Area of Science:
- Neuroscience
- Neurodevelopmental Biology
- Neuropharmacology
Background:
- GABA (γ-aminobutyric acid) is the primary inhibitory neurotransmitter crucial for brain function.
- Maintaining excitation-inhibition (E/I) balance is vital for neural circuit function.
- Imbalances in GABAergic system development are linked to neurodevelopmental disorders.
Purpose of the Study:
- To review how GABAergic system impairments contribute to neurodevelopmental disorders.
- To highlight therapeutic potential of modulating the GABAergic system for cognitive deficits.
Main Methods:
- Literature review of studies on GABAergic development and neurodevelopmental disorders.
- Analysis of research on therapeutic interventions targeting the GABAergic system.
Main Results:
- Perturbations in GABAergic neuron generation and synaptic formation can lead to E/I imbalances.
- These imbalances are implicated in the pathophysiology of various neurodevelopmental disorders.
- Modulating the GABAergic system has shown promise in reversing cognitive deficits in disease models.
Conclusions:
- Therapeutic strategies targeting the GABAergic system hold potential for treating neurodevelopmental disorders.
- Restoring E/I balance through GABAergic modulation may be a viable treatment approach.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Gut-Brain Axis
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Hepatic Encephalopathy
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
